Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2023 Filed May 4, 2023 21:12 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Exercise / conversionCommon Stock | 12,397 | $67.32 | $834,566.04 |
DisclosureSEC source: 0001225208-23-005427 · doc4.xml · nonDerivative · entry 1 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,008.6729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 4, 2023 20:58 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
SaleCommon Stock | 750 | $155.27 | $116,450.40 |
DisclosureSEC source: 0001225208-23-005411 · doc4.xml · nonDerivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,201.799 Read SEC document |
| May 04, 2023 Filed May 5, 2023 17:41 UTC |
KALENKA ROBERT FCorporate Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,357 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001225208-23-005450 · doc4.xml · derivative · entry 7 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,357 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 5, 2023 17:41 UTC |
KALENKA ROBERT FCorporate Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,932 | $0.00 Strike: $98.31 | $0.00 |
DisclosureSEC source: 0001225208-23-005450 · doc4.xml · derivative · entry 6 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,932 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 5, 2023 17:41 UTC |
KALENKA ROBERT FCorporate Vice President
|
SaleCommon Stock | 8,152 | $152.63 | $1,244,207.15 |
DisclosureSEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 5 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,488.4097 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.235 - $153.045, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 04, 2023 Filed May 5, 2023 17:41 UTC |
KALENKA ROBERT FCorporate Vice President
|
SaleCommon Stock | 7,568 | $152.63 | $1,155,073.57 |
DisclosureSEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 4 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,640.4097 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.235 - $153.045, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 04, 2023 Filed May 5, 2023 17:41 UTC |
KALENKA ROBERT FCorporate Vice President
|
SaleCommon Stock | 1,713 | $152.63 | $261,448.34 |
DisclosureSEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 3 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,208.4097 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.235 - $153.045, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 04, 2023 Filed May 5, 2023 17:41 UTC |
KALENKA ROBERT FCorporate Vice President
|
Exercise / conversionCommon Stock | 8,357 | $93.88 | $784,555.16 |
DisclosureSEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 2 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,921.4097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2023 Filed May 5, 2023 17:41 UTC |
KALENKA ROBERT FCorporate Vice President
|
Exercise / conversionCommon Stock | 8,932 | $98.31 | $878,104.92 |
DisclosureSEC source: 0001225208-23-005450 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,564.4097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 18:45 UTC |
Carey Thomas PCorporate VP
|
Tax withholdingCommon Stock | 2,148 | $139.91 | $300,520.24 |
DisclosureSEC source: 0001225208-23-004785 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,754 Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004662 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,935 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 15:03 UTC |
PERNA THOMAS JDirector
|
GrantCommon Stock | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004668 · doc4.xml · nonDerivative · entry 1 PERNA THOMAS J · CIK 0001209487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,895 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004663 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,128 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
keller brettDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004664 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,754 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
keller brettDirector
|
GrantCommon Stock | 36 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004664 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,742 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 15:02 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004660 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,950 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004666 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 837 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004669 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,259 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004669 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,247 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004665 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,765.102 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 63 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004665 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,747.102 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004667 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,281 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004667 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,277 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 05, 2023 Filed Apr 5, 2023 19:03 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004661 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,022 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 20:15 UTC |
keller brettDirector
|
GrantCommon Stock | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004523 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,706 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 20:15 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004524 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 834 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 20:16 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 186 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004526 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,234 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 20:15 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004525 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,272 F1 · shares: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the director's deferral of cash compensation under the Director Deferred Compensation Program and represents a like number of shares of Broadridge common stock (the "DCUs"). The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 16:15 UTC |
Matlin LauraVP, Deputy GC and CGO
|
Tax withholdingCommon Stock | 466 | $146.57 | $68,301.62 |
DisclosureSEC source: 0001225208-23-004518 · doc4.xml · nonDerivative · entry 1 Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,151.696 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC | Tax withholdingCommon Stock | 17,499 | $146.57 | $2,564,828.43 |
DisclosureSEC source: 0001225208-23-004516 · doc4.xml · nonDerivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,014.0271 Read SEC document |
|
| April 01, 2023 Filed Apr 4, 2023 16:15 UTC |
DALY RICHARD JDirector · Executive Chairman
|
Tax withholdingCommon Stock | 742 | $146.57 | $108,754.94 |
DisclosureSEC source: 0001225208-23-004514 · doc4.xml · nonDerivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,427.9949 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:16 UTC |
Reese EdmundCorporate VP and CFO
|
Tax withholdingCommon Stock | 547 | $146.57 | $80,173.79 |
DisclosureSEC source: 0001225208-23-004520 · doc4.xml · nonDerivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,132.45 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Exercise / conversionFY2020 RSUs · Derivative | 1,360 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004522 · doc4.xml · derivative · entry 4 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.exercise_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock. F1 · derivative.expiration_date: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Tax withholdingCommon Stock | 986 | $146.57 | $144,518.02 |
DisclosureSEC source: 0001225208-23-004522 · doc4.xml · nonDerivative · entry 3 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,951.799 F2 · price: Represents the amount of shares withheld to cover tax liabilities upon the vesting of 1,904 performance based Restricted Stock Units that vested and converted into an equal number of shares of common stock on April 1, 2023. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Tax withholdingCommon Stock | 695 | $146.57 | $101,866.15 |
DisclosureSEC source: 0001225208-23-004522 · doc4.xml · nonDerivative · entry 2 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,937.799 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
Exercise / conversionCommon Stock | 1,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-004522 · doc4.xml · nonDerivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,632.799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represented one share of Broadridge common stock and on April 1, 2023 1,360 Restricted Stock Units vested and converted into an equal number of shares of common stock. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
Tax withholdingCommon Stock | 4,004 | $146.57 | $586,866.28 |
DisclosureSEC source: 0001225208-23-004521 · doc4.xml · nonDerivative · entry 1 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,611.6729 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
KALENKA ROBERT FCorporate Vice President
|
Tax withholdingCommon Stock | 1,170 | $146.57 | $171,486.90 |
DisclosureSEC source: 0001225208-23-004517 · doc4.xml · nonDerivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,632.4097 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
PERRY CHRISTOPHER JOHNPresident
|
Tax withholdingCommon Stock | 4,950 | $146.57 | $725,521.50 |
DisclosureSEC source: 0001225208-23-004519 · doc4.xml · nonDerivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,859.528 Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 20:15 UTC |
DESCHUTTER DOUGLAS RICHARDCorporate Vice President
|
Tax withholdingCommon Stock | 1,202 | $146.57 | $176,177.14 |
DisclosureSEC source: 0001225208-23-004515 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Corporate Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,343.8948 Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 20:15 UTC |
Duelks Robert NDirector
|
SaleCommon Stock | 1,425 | $141.06 | $201,017.06 |
DisclosureSEC source: 0001225208-23-002853 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BOMAR II LLC Disclosed balance after: 6,275 Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 15:43 UTC |
Matlin LauraVP, Deputy GC and CGO
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002237 · doc4.xml · derivative · entry 1 Matlin Laura · CIK 0001658944 · VP, Deputy GC and CGO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC | GrantStock Option (Right to Buy) · Derivative | 135,366 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002234 · doc4.xml · derivative · entry 1 Gokey Timothy C · CIK 0001296187 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,366 Underlying: Common Stock · 135,366 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
|
| February 15, 2023 Filed Feb 17, 2023 15:43 UTC |
DALY RICHARD JDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 5,714 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002232 · doc4.xml · derivative · entry 1 DALY RICHARD J · CIK 0001198860 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,714 Underlying: Common Stock · 5,714 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
Reese EdmundCorporate VP and CFO
|
GrantStock Option (Right to Buy) · Derivative | 30,716 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002241 · doc4.xml · derivative · entry 1 Reese Edmund · CIK 0001833903 · Corporate VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,716 Underlying: Common Stock · 30,716 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
Stingi Richard JohnCorporate VP and CHRO
|
GrantStock Option (Right to Buy) · Derivative | 8,571 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002240 · doc4.xml · derivative · entry 1 Stingi Richard John · CIK 0001846577 · Corporate VP and CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,571 Underlying: Common Stock · 8,571 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
SCHIFELLITE ROBERTCorporate SVP
|
GrantStock Option (Right to Buy) · Derivative | 26,073 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002239 · doc4.xml · derivative · entry 1 SCHIFELLITE ROBERT · CIK 0001391090 · Corporate SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,073 Underlying: Common Stock · 26,073 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
PERRY CHRISTOPHER JOHNPresident
|
GrantStock Option (Right to Buy) · Derivative | 37,502 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002238 · doc4.xml · derivative · entry 1 PERRY CHRISTOPHER JOHN · CIK 0001619128 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,502 Underlying: Common Stock · 37,502 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:43 UTC |
KALENKA ROBERT FCorporate Vice President
|
GrantStock Option (Right to Buy) · Derivative | 6,357 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002236 · doc4.xml · derivative · entry 1 KALENKA ROBERT F · CIK 0001391091 · Corporate Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,357 Underlying: Common Stock · 6,357 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 20:42 UTC |
Carey Thomas PCorporate VP
|
GrantStock Option (Right to Buy) · Derivative | 23,572 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001225208-23-002231 · doc4.xml · derivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,572 Underlying: Common Stock · 23,572 shares Expires 2033-02-15 F1 · derivative.exercise_date: Stock options vest equally over 4 years beginning February 15, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.